CompletedPHASE1, PHASE2NCT01100463

Study of 0.1% Uracil Topical Cream (UTC) for the Prevention of Hand-Foot Syndrome

Studying Hereditary breast cancer

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Nanometics (d.b.a. PHD Biosciences)
Principal Investigator
James Cantrell, MD
Birmingham Hematology/Oncology Associates
Intervention
Cream(drug)
Enrollment
18 enrolled
Eligibility
18 years · FEMALE
Timeline
20102011

Study locations (6)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01100463 on ClinicalTrials.gov

Other trials for Hereditary breast cancer

Additional recruiting or active studies for the same condition.

See all trials for Hereditary breast cancer

← Back to all trials